Board has considered and approved unaudited financial result for the quarter ended June, 2026

INTEGRATED PROTEINS LIMITED Manek Centre,Of(cid:976)ice No 218,P N Marg,Jamnagar – 361008, Gujarat,India Phone:9428817400 Email ID: integrated.pl2024@gmail.com Website: www.integratedproteins.com CIN: L62013GJ1992PLC018426 Date: 14/08/2026 BSE Limited Phiroz Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Ref : Scrip Code ‐ 519606 Sub: Outcome of the meeting of the Board of Directors held on Friday, 14th August, 2026 pursuant to regulation 30 & 33 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulation, 2015. Dear Sir/Madam, With reference to above subject and in compliance with Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Meeting of the Board of Director held on today i.e., Friday, 14th August, 2026, at the registered office of the company to consider and approve the Unaudited Financial Results for the Quarter ended on 30th June, 2026 along with the Limited Review Report by the auditors. The aforesaid board meeting commenced at 13:00 HRS (IST) and concluded at 15:50 HRS (IST). You are requested to take above on your records. Thanking you, Yours Faithfully, For and on behalf of INTEGRATED PROTEINS LIMITED Hiren Shah DIN: 09842161 MANAGING DIRECTOR INTEGRATED PROTEINS LIMITED CIN: L62013GJ1992 PLCO 18426 Registered Office: office No. 218, Manek Centre, Pandit Nehru Marg, Patel Colony, Jamnagar, Jarnnagar, Gujarat, India, 361008 Unaudited Standalone Statement of Financial Results for the Quarter Ended 30-06-2026 (Rs. In Lakh except per share data) Quarter Ended Year Ended Particulars 30-06-2026 31-03-2026 30-06-2025 31-03-2026 A Date of start of reporting period 01-04-2026 01-01-2026 01-04-2025 01-04-2025 B Date of end of reporting period 30-06-2026 31-03-2026 30-06-2025 31-03-2026 Whether results are audited or unaudited Unaudited Audited Unaudited Audited D Nature of report Standalone or Consolidated Standalone Standalone Standalone Standalone Part I -Revenue From Operations Net sales or Revenue from Operations 1,054.73 569.03 993.57 Other lncome 1.65 0.50 4.72 0.50 Total Income (| + Il) 1,056.38 569.53 4.72 994.07 Expenses (a)Cost of materials consumed (b) Purchases of stock-in-trade 1,001.10 542.74 950.14 (c)|Changes in inventories of finished goods, work-in-progress and stock-in-trade (d)Employee benefıt expense 1.02 0.54 0.68 3.16 (e)Finance Costs ()Depreciation and amortisation expense (g)Other Expenses 5.81 3.11 4.04 12.43 Total expenses 1,007.93 546.39 4.71 965.74 Profit (loss) before Exceptional and Extraordinary Items and tax (!I|-1V) 48.45 23.14 0.01 28.33 VI Exceptional items VIII Profit (loss) before Tax (V-VI) 48.45 23.14 0.01 28.33 Tax Expense a Current Tax 12.19 4.14 5.83 (Less ):-MAT Credıt lCurrent Tax Expense Relating to Prior years (b) Deferred Tax (Asset)/Liabilıties XI Net Profit/Loss for the period from Continuing Operations (|X |X) 36.26 19.00 0.01 22.50 XII Profit (Loss) from Discontınuing Operaitons XITax Expenses of Discontinuing Operations XIV Net Profit (Loss) from Discontinuing Operartions after tax (Xl1 X Profit (Loss) for the period (XI+XIV) 36.26 19.00 0.01 22.50 XV Other Comprehensive Income a ).Amount of item that will not be reclassifed to profit or loss 1). Income tax relatıng to Items that will not be reclassifed to Iprofit or loss b i). Item that will be reclassifed to profit or loss ). Income tax relating to items that will be reclassifed to profıt or loss XVILTotal Comprehensive income 0.00 0.00 0.00 0.00 Total Comprehensive income |Comprising Profit for the Period ( After tax) and Other comprehensive incomel |(xv+xvi) 36.26 19.00 0.01 22.50 XVIIL Details of equity share capital Paid-up equity share capıtal (Face Value of Rs. 10/-per equily |share) 1,871.36 1,871.36 352.02 1,871.36 Face value of equity share capıtal (Per Share) Rs. 10/ Rs. 10/ Rs. 10/ Rs. 10/ Tother Equity GRAD XIX Earnings per share (Not Annualized for Year ended) 0.19 0.10 0.00 0.12 Earnings per share Continuing Operation ( Not Annualised for Year ended Basic earnings per share before extraordinary items 0.19 0.10 0.00 0.12 Diluted earnings per share before extraordinary items 0.19 0.10 0.00 0.12 Earnings per share Discontinuing Operation ( Not Annualised (b) for Year ended) Basic earnings per share after extraordinary items 0.00 0.00 0.00 0.00 |Diluted earnings per share after extraordinary items 0.00 0.00 0.00 0.00 (c)Earnings per share ( Not Annualised for Year ended Basic earnings per share before extraordinary items 0.19 0.10 0.00 0.12 Diluted earnings per share before extraordinary items 0.19 0.10 0.00 0.12 Notes: Notes to Unaudited Standalone financials results for the quarter ended 30t h June 2026: The unaudited standalone financial results are prepared in accordance with the Indian Accounting Standards 34 "Interim Financial Reporting" as prescribed under 1 Section 133 of the Companies Act. 2013, read with Rule 3 of the Companies (indian Accounting Standards) Rules, 2015 and Companies (Indian Accounting Standards Amendment Rules 2016. The figures for the correspondıng previous period have been regrouped / reclass ified wherever necessary, to make them comparable. The Audit Committee has reviewed the above results and the Board of Directors has apprcved the above results and its release at their respective meetings held on 14 August, 2026 The Company has multiple reportable business segment. Hence, separate information for segment wise disclosure is given in accordance with the requirements of |Indıan Accounting Standard (Ind AS) 108 -"Operating Segments" FOR, JNTEGRATED PROTEINS LIMITED EDP R OTE Hiren Shah Date:- 14 August, 2026 Managing Director DIN : 09842 161 Place :- Jamnagar INTEGRATED PROTEINS LIMITED CIN:L62013GJ1992PLCO18426 Registered Office : Office No. 218, Manek Centre, Pandit Nehru Marg, Patel Colony, Jamnagar, Jamnagar, Gujarat, India, 361008 Reporting of Segment wise Revenue, Results and Capital Employed along financial results for the Quarter ended on June 30, 2026 R In Lakh except per share data) Particulars Quarter ended Year Ended Date of start,of reporting perlod 03 10 -- 00 46 -- 220 02 26 6 03 11 -- 00 13 -- 22 00 22 66 03 10 -- 00 46 -- 22 00 22 55 03 11 -- 00 43 -- 22 00 22 56 Date of end of reporting period 30-06-2026 31-03-2026 30-06-2025 Whether results are audlted or unaudited 31-03-2026 D Nature of report standalone or consolidated STUn Aa Nu Ddi At Le Od. N E STA Au Nd Di At Le Od NE SÚ Tn Aa Nu Dd Ai Lte Od N E STA Au Nd Di At Led O NE Segment Revenue 1 (net sale/income from each segment should be disclosed under this head) (( ba )) |S Se eg gm me en nt t - -TA exg tr io l& e T rading 1.051.23 17.78 437.60 (C) |Segment-Securities 461.63 461.63 (d Segment-Medical 3.50 89.62 4.72 94.34 (e) Segment -Real estate 0.50 0.50 0.5d Total 1,055.23 569.51 4.72 994.0 Less: Inter Segment Revenue Net sales/lncome From Operations 1,055.23 569.53 4.71 994.07 2 Segment Results (Profit)( +)/ Loss (-) before tax and interest |from Each segment)# (a) Segment -Agro&Trading (b) |Segment -Textile 51.93 0.81 13.22 5.24 5.24 (C Segment-Securities (d Segment-Medical 0.50 19.89 4.77 23.98 (e ) Segment -Real estate 0.50 0.50 0.50 (f) Unallocable 1.15 Total 54.08 26.44 4.71 42.94 Finance Cost 5.63 3.30 4.7 14.61 Other Un-allocable Expenditure net off Un-allocable income 5.63 3.30 4.71 14.61 Total Profit Before Taxl 48.45 23.14 0.01 28.33 3 Capital Employed (Segment assets -Segment Liabilities) 3(1) Segment Assets (a Segment - Agroa Trading (b Segment -Textile 67.17 26.18 0.7d 26.18 184.70 ( (dC S Se eg gm me en nt t- -MS eec du ir ci at li es 1,3 17 56 0. .1 01 1, 15 53 01. .3 02 1,750.31 1,51 38 14 .. 327 0 ( (e g S Une ag lm le on ct a b- leR eal estate 31 84 40. .5 75 9 15 10 5. .5 54 3 1,05 34 7. .7 745 11 55 0 10 . 5. 50 .40 5 3 Total 2,118.62 2,058.27 2,843.5O 2,058.27 3(2 Segment Llabllittes (a Segment -AgroaTrading (b Segment -Textile 10.29 (c) [Showing first 8,000 characters — download PDF for full document]